Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Payables (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Payables for 9 consecutive years, with $36.6 million as the latest value for Q4 2025.

  • Quarterly Payables fell 5.49% to $36.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.6 million through Dec 2025, down 5.49% year-over-year, with the annual reading at $36.6 million for FY2025, 5.49% down from the prior year.
  • Payables hit $36.6 million in Q4 2025 for Inspire Medical Systems, down from $59.2 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $59.2 million in Q3 2025 to a low of $9.1 million in Q1 2021.
  • Historically, Payables has averaged $32.3 million across 5 years, with a median of $34.3 million in 2024.
  • Biggest five-year swings in Payables: soared 223.2% in 2022 and later plummeted 33.48% in 2025.
  • Year by year, Payables stood at $20.9 million in 2021, then rose by 28.74% to $26.8 million in 2022, then surged by 44.67% to $38.8 million in 2023, then decreased by 0.39% to $38.7 million in 2024, then dropped by 5.49% to $36.6 million in 2025.
  • Business Quant data shows Payables for INSP at $36.6 million in Q4 2025, $59.2 million in Q3 2025, and $53.2 million in Q2 2025.